Table A1.
Finding in Patienta |
|||||
Patient | PCR Set 1 | Sequence Set 1 | PCR Set 2 | Sequence Set 2 | Conclusionb |
SoS 3 | + | + | + | + | + |
SoS 14 | + | + | + | + | + |
SoS 17 | + | + | + | + | + |
SoS 18 | + | + | + | + | + |
SoS 21 | + | + | + | + | + |
SoS 24 | + | + | + | + | + |
SoS 26 | + | + | + | + | + |
SoS 27 | + | + | + | + | + |
SoS 33 | + | + | + | + | + |
SoS 36 | + | + | + | + | + |
SoS 41 | + | + | + | + | + |
SoS 46 | + | + | + | + | + |
SoS 48 | + | + | + | + | + |
SoS 64 | + | + | + | + | + |
SoS 65 | + | + | + | + | + |
SoS 73 | + | + | + | + | + |
SoS 79 | + | + | + | + | + |
SoS 80 | + | + | + | + | + |
SoS 93 | + | + | + | + | + |
SoS 94 | + | + | + | + | + |
SoS 101 | + | + | + | + | + |
SoS 112 | + | + | + | + | + |
SoS 114 | + | + | + | + | + |
SoS 146 | + | + | + | + | + |
Sos 156 | + | + | + | + | + |
SoS 11 | + | + | − | + | |
SoS 32 | + | + | − | + | |
SoS 42 | + | + | − | + | |
SoS 61 | + | + | − | + | |
SoS 102 | + | + | − | + | |
SoS 40 | − | + | + | + | |
SoS 66 | − | + | + | + | |
SoS 67 | − | + | + | + | |
SoS 72 | − | + | + | + | |
SoS 74 | − | + | + | + | |
SoS 103 | − | + | + | + | |
SoS 107 | + | − | + | + | + |
SoS 5 | + | − | − | − | |
SoS 110 | + | − | − | − | |
SoS 4 | − | − | − | ||
SoS 12 | − | − | − | ||
SoS 31 | − | − | − | ||
SoS 69 | − | − | − | ||
SoS 71 | − | − | − | ||
SoS 85 | − | − | − | ||
SoS 96 | − | − | − | ||
SoS 100 | − | − | − |
Note.— Blank spaces in the appendix indicate that sequences could not be performed (because of a negative PCR result).
+ = positive result; − = negative result.
Refers to whether or not the breakpoint is identified on the basis of the PCR and sequence results of sets 1 and 2.